Guiseppe Lanzino, M.D., of the Department of Neurosurgery discusses the pipeline embolization device, a new therapeutic approach for patients with large cerebral aneurysms located along the proximal segment of the intracranial carotid artery.
Large, giant and wide-necked aneurysms are traditionally challenging to treat effectively. In this flow diversion technique, a device is placed across the aneurysm neck to divert blood flow back to the normal vessel and eventually lead to occlusion of the aneurysm.
Dr. Lanzino and Mayo Clinic were involved in early clinical studies leading to U.S. Food and Drug Administration (FDA) approval of this device.
